Malignant neoplasm of the axillary tail of the left female breast is a type of breast cancer that originates in the axillary tail region, which is an extension of breast tissue towards the armpit. This condition is clinically significant due to its potential for metastasis and the need for timely diagnosis and treatment. The ICD-10 Code C50.612 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this malignancy.
What is ICD-10 Code C50.612 for Malignant neoplasm of axillary tail of left female breast?
ICD-10 Code C50.612 specifically denotes a malignant neoplasm located in the axillary tail of the left female breast. This code is utilized in clinical documentation and billing when diagnosing breast cancer that affects this particular area. It is essential for capturing the severity and location of the disease, which aids in treatment planning and resource allocation.
ICD-10 Code C50.612 – Clinical Definition and Explanation of Malignant neoplasm of axillary tail of left female breast
Malignant neoplasm of the axillary tail of the left female breast is characterized by the uncontrolled growth of abnormal cells in the breast tissue extending towards the axilla. This condition can progress rapidly and requires prompt medical intervention to prevent further complications. Early detection is crucial for effective treatment and improved patient outcomes.
Key Clinical Features:
- Presence of a palpable mass in the axillary region.
- Possible lymphadenopathy in the axillary lymph nodes.
- Symptoms may include localized pain or discomfort.
- Mammography may reveal irregularities in breast tissue.
ICD-10 Code C50.612 for Malignant neoplasm of axillary tail of left female breast – SOAP Notes & Clinical Use
ICD-10 Code C50.612 is integral to SOAP notes, serving to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
What Does ICD-10 Code C50.612 for Malignant neoplasm of axillary tail of left female breast Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C50.612 connects subjective patient-reported symptoms with objective clinical findings, leading to a formal diagnosis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C50.612 – Malignant neoplasm of axillary tail of left female breast
The management of malignant neoplasm of the axillary tail of the left female breast typically requires a multidisciplinary approach, including surgical intervention, chemotherapy, and radiation therapy.
Antibiotic Therapy:
Supportive Care:
- Pain management through analgesics.
- Nutritional support to maintain strength.
- Psychosocial support for emotional well-being.
Infection Control:
How to Document Symptoms of Malignant neoplasm of axillary tail of left female breast (ICD-10 C50.612) in SOAP Notes
Subjective:
- Patient reports a lump in the left axillary region.
- Complaints of intermittent pain in the left breast.
- History of breast cancer in the family.
- Noted changes in breast appearance.
Objective:
- Palpable mass in the left axillary tail.
- Tenderness noted upon examination.
- Mammogram shows irregular mass.
- Ultrasound confirms the presence of a solid lesion.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Malignant neoplasm of axillary tail of left female breast (ICD-10 Code C50.612)
Assessment:
- Diagnosis: Malignant neoplasm of axillary tail of left female breast, Stage II.
- ICD-10 Code: C50.612.
- Contributing factors: Family history of breast cancer.
- Patient presents with significant symptoms warranting intervention.
Plan:
- Refer to oncology for chemotherapy evaluation.
- Schedule surgical consultation for potential mastectomy.
- Initiate pain management protocol.
- Arrange follow-up appointments for monitoring.
Treatment & Plan Section for ICD-10 Code C50.612 – Malignant neoplasm of axillary tail of left female breast
- Chemotherapy as a first-line treatment option.
- Surgical intervention may include lumpectomy or mastectomy.
- Radiation therapy to target residual cancer cells.
- Regular follow-up imaging to monitor treatment response.
Using ICD-10 Code C50.612 for Malignant neoplasm of axillary tail of left female breast in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and findings in SOAP notes.
- Use C50.612 in appropriate clinical settings for billing.
- Align treatment plans with clinical guidelines to support justified billing.
- Document any relevant comorbidities that may affect treatment.
Related ICD-10 Codes Often Used with Malignant neoplasm of axillary tail of left female breast
ICD-10 Code C50.612 in Medical Billing and Insurance for Malignant neoplasm of axillary tail of left female breast
ICD-10 Code C50.612 is crucial for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for services rendered.
Billing Notes:
- Document all relevant clinical findings to support the use of C50.612.
- Use this code in conjunction with treatment codes for comprehensive billing.
- Ensure that the diagnosis is clearly linked to the treatment provided.
- Maintain updated records to facilitate claims processing.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 19301 | Mastectomy, total (including axillary lymphadenectomy) |
| 96413 | Chemotherapy administration, intravenous, push technique |
| 77067 | Breast ultrasound, bilateral |
| 99214 | Established patient office visit, level 4 |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C50.612 for Malignant neoplasm of axillary tail of left female breast
What are the common symptoms of malignant neoplasm of the axillary tail?
Common symptoms include a palpable mass in the axillary region, localized pain, and changes in breast appearance. Patients may also experience lymphadenopathy in the axillary lymph nodes.
How is the diagnosis of this condition confirmed?
Diagnosis is typically confirmed through imaging studies such as mammography and ultrasound, followed by a biopsy to assess the histological characteristics of the tumor.
What treatment options are available for this condition?
Treatment options may include surgical intervention, chemotherapy, and radiation therapy, depending on the stage and characteristics of the tumor.
How does this code affect billing and insurance claims?
ICD-10 Code C50.612 is essential for accurate billing and insurance claims, as it specifies the diagnosis and supports the medical necessity of the treatments provided.
